Genmab A (GMAB) Non-Current Debt: 2019-2020

Historic Non-Current Debt for Genmab A (GMAB) over the last 2 years, with Dec 2020 value amounting to $41.6 million.

  • Genmab A's Non-Current Debt rose 31.12% to $41.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $41.6 million, marking a year-over-year increase of 31.12%. This contributed to the annual value of $41.6 million for FY2020, which is 31.12% up from last year.
  • Per Genmab A's latest filing, its Non-Current Debt stood at $41.6 million for FY2020, which was up 31.12% from $31.7 million recorded in FY2019.
  • In the past 5 years, Genmab A's Non-Current Debt ranged from a high of $41.6 million in FY2020 and a low of $31.7 million during FY2019.
  • Its 2-year average for Non-Current Debt is $36.7 million, with a median of $36.7 million in 2019.
  • Data for Genmab A's Non-Current Debt shows a peak YoY soared of 31.12% (in 2020) over the last 5 years.
  • Over the past 2 years, Genmab A's Non-Current Debt (Yearly) stood at $31.7 million in 2019, then soared by 31.12% to $41.6 million in 2020.